CID 170647464
Dabogratinib
Structural Information
- Molecular Formula
- C25H24Cl2N6O3S
- SMILES
- C[C@H](C1=C(C=NC=C1Cl)Cl)OC2=CC3=C(C=C2)NN=C3C4=CN=C(C=C4)N5CC6(C5)CN(C6)S(=O)(=O)C
- InChI
- InChI=1S/C25H24Cl2N6O3S/c1-15(23-19(26)9-28-10-20(23)27)36-17-4-5-21-18(7-17)24(31-30-21)16-3-6-22(29-8-16)32-11-25(12-32)13-33(14-25)37(2,34)35/h3-10,15H,11-14H2,1-2H3,(H,30,31)/t15-/m1/s1
- InChIKey
- JOAFWIHZEBKYQK-OAHLLOKOSA-N
- Compound name
- 5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-[6-(2-methylsulfonyl-2,6-diazaspiro[3.3]heptan-6-yl)pyridin-3-yl]-1H-indazole
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 559.10805 | 202.6 |
[M+Na]+ | 581.08999 | 209.7 |
[M-H]- | 557.09349 | 207.0 |
[M+NH4]+ | 576.13459 | 194.1 |
[M+K]+ | 597.06393 | 208.1 |
[M+H-H2O]+ | 541.09803 | 182.1 |
[M+HCOO]- | 603.09897 | 198.6 |
[M+CH3COO]- | 617.11462 | 206.9 |
[M+Na-2H]- | 579.07544 | 201.8 |
[M]+ | 558.10022 | 223.1 |
[M]- | 558.10132 | 223.1 |